Quantcast
Last updated on April 18, 2014 at 1:21 EDT

Latest Fox Chase Stories

2014-04-09 11:41:42

Results from the study could help determine potential treatment options A quartet of proteins that play critical roles in cell replication, cell death, and DNA repair could lead to better targets for therapy against treatment-resistant head-and-neck squamous cell cancers. In a study to be presented at the AACR Annual Meeting 2014 on Tuesday, April 8, Ranee Mehra, MD, a medical oncologist who specializes in head and neck cancers at Fox Chase Cancer Center, and colleagues, showed a...

2014-04-09 10:50:26

By incapacitating the activities of a protein that guides other proteins to fold into a stable shapes, Fox Chase Cancer Center researchers shut off the spigot for two proteases that help ovarian cancer cells chew their way out of the tissue they grow in and dig in at new locations. Building on earlier work that showed that inhibition of heat shock proteins—the protein origami helpers—limited metastases in ovarian cancer in mice, Shane W. O'Brien, MS, Scientific Assistant at Fox Chase...

2013-10-29 23:18:40

Avery's Pet Styling Salon and Boutique sponsored the Annual Fox Chase Cancer Center’s “Paws for the Cause” dog walk fundraiser for cancer research. Philadelphia, PA (PRWEB) October 29, 2013 Avery’s Mobile Pet Spa is dedicated to taking a big bite out of Cancer. On Sunday, October 20th the mobile pet spa grooming team showed their bite was as big as their bark when they joined hundreds of dogs and their owners in Northeast Philadelphia at Fox Chase Cancer Center for its Annual...

2013-01-07 14:54:23

Blueprint could help guide treatment for patients who have exhausted all other options Fox Chase Cancer Center, a National Cancer Institute-designated Comprehensive Cancer Center, is now offering patients with advanced cancer a cutting-edge clinical test that will provide them with a unique blueprint of their cancer genes. The new clinical test, known as CancerCode-45TM, evaluates an individual's tumor for genetic alterations in a select group of 45 genes and gives physicians the...

2013-01-07 00:20:43

Blueprint could help guide treatment for patients who have exhausted all other options PHILADELPHIA, Jan. 7, 2013 /PRNewswire-USNewswire/ -- Fox Chase Cancer Center, a National Cancer Institute-designated Comprehensive Cancer Center, is now offering patients with advanced cancer a cutting-edge clinical test that will provide them with a unique blueprint of their cancer genes. The new clinical test, known as CancerCode-45(TM), evaluates an individual's tumor for genetic...

2012-12-10 15:15:20

Inflammatory breast cancer (IBC) is a very rare and aggressive disease that progresses rapidly and is associated with a very low survival rate. To understand how this type of cancer spreads, it's crucial to characterize the interactions between cancer cells and their 3D environment. Researchers at Fox Chase Cancer Center have developed a novel, 3D culture system that mimics the environment surrounding these cancer cells. This model could be used to test new anticancer drugs capable of...

2012-12-10 12:23:39

Results show that the drug could extend progression-free survival Previous research has shown that a family of genes, proteins and enzymes called the uPA system (for urokinase plasminogen activator) plays an active role in different facets of cancer's biology, including tumor cell invasion, the spread of metastases, and the growth of a primary tumor. Mesupron® is a new small molecule inhibitor, taken as a pill, that inhibits the uPA system. The results from a recent phase II clinical...

2012-12-03 00:20:16

PHILADELPHIA, Dec. 3, 2012 /PRNewswire-USNewswire/ -- On March 1, 2013, leading cancer center administrator and nationally recognized hematology/oncology expert Richard I. Fisher, MD, will assume a set of vital leadership roles at Fox Chase Cancer Center, a member of the Temple University Health System, and Temple University School of Medicine. Currently, Fisher is vice president for strategic and program development at the University of Rochester Medical Center, where he is also the Samuel...

2012-04-04 20:20:57

The new model may provide scientists with a better understanding of the disease and help with developing effective interventions Inflammatory breast cancer (IBC) is a very aggressive, often misunderstood type of cancer that is diagnosed more frequently in younger women compared with other types of breast cancer. The five-year survival rate is between 25 and 50 percent–significantly lower than the survival rate for other types of breast cancer. The reason for the poor prognosis is...

2011-10-05 14:31:26

In a new study led by Fox Chase Cancer Center radiation oncologist Natasha Townsend, M.D., researchers have found that Gleason scores determined by pathologists at Fox Chase Cancer Center more accurately predict the risk of recurrence than Gleason scores from referring institutions. She presented the new research at the 53rd Annual Meeting of the American Society for Radiation Oncology on Monday, October 3. When a man is diagnosed with prostate cancer, his tumor is assigned a Gleason score...